Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

Caitlin E. Cox

December 18, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

Body Fat Distribution Influences Cardiovascular Age

Todd Neale

August 22, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Conference News ACC 2023

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

L.A. McKeown

March 04, 2023

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

L.A. McKeown

June 23, 2021

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Daily News

Big Fitness Equals Big Survival Benefit, New Study Shows

Michael O'Riordan

October 22, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Michael O'Riordan

December 12, 2017

News Daily News

Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say

Caitlin E. Cox

October 10, 2017

News Daily News

Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s

Alison Palkhivala

April 11, 2017

News Daily News

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Michael O'Riordan

June 14, 2016

Advertisement

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

October 2025 Dispatch for the CV Team

Body Fat Distribution Influences Cardiovascular Age

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Inactivity Pandemic Poised to Undo CVD Prevention Advances

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Big Fitness Equals Big Survival Benefit, New Study Shows

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say

Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content